60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q2 Loss, Tops Revenue Estimates

60 Degrees Pharmaceuticals Inc. (SXTP) came out with a quarterly loss of $4.23 per share versus the Zacks Consensus Estimate of a loss of$ 3.96. This compares to loss of $16.81 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -6.82%. A quarter ago, it was expected that this company would post a loss of$ 1.92 per share when it actually produced earnings of $0.36, delivering a surprise of 118.75%. Over the last four quarters, th ...